XML 34 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Employee Benefit Plans
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]
Note
1
3
. Employee Benefit Plans
 
Defined Benefit Plans
 
The Company maintains
two
nonqualified domestic, noncontributory defined benefit plans (the “Benefit Plans”) for key members of senior management and non-management directors. The Company’s unfunded Benefit Plans include the Supplemental Executive Retention Plan (“SERP”) and the Directors’ Supplemental Retirement Plan (“Directors’ Plan”). The SERP provides for a defined benefit, at normal retirement age, targeted at
35%
of the participant’s projected final average compensation, subject to a defined maximum annual benefit. Benefits under the SERP generally become payable at age
62.
The Directors’ Plan provides for a defined benefit, at normal retirement age, up to
100%
of the participant’s highest consecutive
three
-year average compensation. Benefits under the Directors’ Plan generally become payable at age
70.
The following table presents the changes in the aggregate actuarial benefit obligation during the periods indicated:
 
   
December 31,
 
   
2018
   
2017
 
(Amounts in thousands)
 
 
 
 
 
 
 
 
Beginning balance
  $
9,635
    $
9,181
 
Plan change
   
-
     
258
 
Service cost
   
245
     
231
 
Interest cost
   
358
     
372
 
Actuarial gain
   
(565
)    
(48
)
Benefits paid
   
(408
)    
(359
)
Ending balance
  $
9,265
    $
9,635
 
 
The following table presents the components of net periodic pension cost, the effect on the consolidated statements of income, and the assumed discount rate for the periods indicated:
 
 
   
Year Ended December 31,
   
   
2018
   
2017
   
2016
 
Income Statement Location
(Amounts in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost
  $
245
    $
231
    $
184
 
Salaries and employee benefits
Interest cost
   
358
     
372
     
382
 
Other expense
Amortization of prior service cost
   
228
     
228
     
226
 
Other expense
Amortization of losses
   
57
     
31
     
47
 
Other expense
Net periodic cost
  $
888
    $
862
    $
839
 
 
                           
Assumed discount rate
   
4.28
%    
3.85
%    
4.22
%
 
 
The following schedule presents the projected benefit payments to be paid under the Benefit Plans, by year, as of
December 31, 2018:
 
(Amounts in thousands)
 
 
 
 
2019
  $
478
 
2020
   
578
 
2021
   
635
 
2022
   
635
 
2023
   
634
 
2024 through 2028
   
3,391
 
 
Deferred Compensation Plan
 
The Company maintains deferred compensation agreements with certain current and former officers that provide benefit payments, over various periods, commencing at retirement or death. There were
no
accrued benefits, which are based on the present values of expected payments and estimated life expectancies, as of
December 31, 2018
or
2017.
There was
no
deferred compensation plan expense in
2018,
compared to
$11
thousand in
2017
and
$60
thousand in
2016.
 
Employee Welfare Plan
 
The Company provides various medical, dental, vision, life, accidental death and dismemberment, and long-term disability insurance benefits to all full-time employees who elect coverage under this program. A
third
-party administrator manages the health plan. Monthly employer and employee contributions are made to a tax-exempt employee benefits trust where the
third
-party administrator processes and pays claims. As of
December 31, 2018,
stop-loss insurance coverage generally limits the Company’s risk of loss to
$150
thousand for individual claims and
$4.20
million for aggregate claims. Health plan expenses were
$3.72
million in
2018,
$3.50
million in
2017,
and
$3.48
million in
2016.
 
Employee Stock Ownership and Savings Plan
 
The Company maintains the Employee Stock Ownership and Savings Plan (“KSOP”) that consists of a
401
(k) savings feature that covers all employees that meet minimum eligibility requirements. The Company matches employee contributions at levels determined by the Board of Directors annually. These contributions are made in the
first
quarter following each plan year and employees must be employed on the last day of the plan year to be eligible. Matching contributions to qualified deferrals under the
401
(k) savings component of the KSOP totaled
$1.06
million in
2018,
$1.18
million in
2017,
and
$1.50
million in
2016.
The KSOP held
366,969
shares of the Company’s common stock as of
December 31, 2018,
387,935
shares as of
December 31, 2017,
and
410,384
shares as of
December 31, 2016.
 
Equity-Based Compensation Plans
 
The Company maintains equity-based compensation plans to promote the long-term success of the Company by encouraging officers, employees, directors, and other individuals performing services for the Company to focus on critical long-range objectives. The Company’s equity-based compensation plans include the
2012
Omnibus Equity Compensation Plan (
“2012
Plan”),
2004
Omnibus Stock Option Plan,
2001
Director’s Option Plan,
1999
Stock Option Plan, and various other plans obtained through acquisitions. As of
December 31, 2018,
the
2012
Plan was the only plan available for the issuance of future grants. All plans issued or obtained before the
2012
Plan are frozen and
no
new grants
may
be issued; however, any options or awards unexercised and outstanding under those plans remain in effect per their respective terms. The
2012
Plan authorized
600,000
shares available for potential grants of incentive stock options, nonqualified stock options, performance awards, restricted stock, restricted stock units, stock appreciation rights, bonus stock, and stock awards. Grants issued under the
2012
Plan state the period of time the grant
may
be exercised,
not
to exceed more than
ten
years from the date granted. The Company’s Compensation and Retirement Committee determines the vesting period for each grant; however, if
no
vesting period is specified the vesting occurs in
25%
increments on the
first
four
anniversaries of the grant date.
 
The following table presents the pre-tax compensation expense and excess tax benefit recognized in earnings for all equity-based compensation plans for the periods indicated:
 
     
Year Ended December 31,
 
     
2018
   
2017
   
2016
 
(Amounts in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Pre-tax compensation expense
  $
1,158
    $
790
    $
531
 
Excess tax benefit
   
95
     
17
     
174
 
 
Stock Options
 
The following table presents stock option activity and related information for the year ended
December 31, 2018:
 
   
 
 
 
 
Weighted Average
   
Weighted Average
   
Aggregate
 
   
Option
   
Exercise Price
   
Remaining Contractual
   
Intrinsic
 
(Amounts in thousands,
 
Shares
   
Per Share
   
Term (Years)
   
Value
 
except share and per share data)
                               
Outstanding, January 1, 2018
   
200,704
    $
20.14
     
 
     
 
 
Granted
   
-
     
-
     
 
     
 
 
Exercised
   
(24,186
)    
15.89
     
 
     
 
 
Canceled
   
(20,263
)    
19.72
     
 
     
 
 
Outstanding, December 31, 2018
   
156,255
    $
20.85
     
5.6
    $
1,662
 
Exercisable, December 31, 2018
   
103,090
    $
20.23
     
4.6
    $
1,160
 
 
The following table presents the total options granted and the weighted average assumptions used to estimate the fair value of those options during the periods indicated. There were
no
options granted in
2018.
 
   
Year Ended December 31,
 
   
2017
   
2016
 
                 
Stock options granted
   
22,849
     
32,768
 
Grant-date fair value per share
  $
5.79
    $
4.01
 
Volatility
   
27.86
%    
25.04
%
Risk-free rate
   
2.17
%    
1.56
%
Expected dividend yield
   
2.99
%    
3.09
%
Expected term (in years)
   
6.50
     
6.50
 
 
The intrinsic value of options exercised was
$423
thousand in
2018,
$84
thousand in
2017,
and
$434
thousand in
2016.
As of
December 31, 2018,
unrecognized compensation cost related to nonvested stock options totaled
$65
thousand with an expected weighted average recognition period of
1.08
years. The actual compensation cost recognized might differ from this estimate due to various items, including new grants and changes in estimated forfeitures.
 
Restricted Stock Awards
 
The following table presents restricted stock activity and related information for the year ended
December 31, 2018:
 
   
 
 
 
 
Weighted Average
 
   
Shares
   
Grant-Date Fair Value
 
                 
Nonvested, January 1, 2018
   
43,606
    $
23.49
 
Granted
   
41,339
     
30.08
 
Vested
   
(33,832
)    
25.69
 
Canceled
   
-
     
-
 
Nonvested, December 31, 2018
   
51,113
    $
27.37
 
 
As of
December 31, 2018,
unrecognized compensation cost related to nonvested restricted stock awards totaled
$927
thousand with an expected weighted average recognition period of
1.95
years. The actual compensation cost recognized might differ from this estimate due to various items, including new awards granted and changes in estimated forfeitures.